| Literature DB >> 29894482 |
Takao Konishi1,2, Naohiro Funayama1, Tadashi Yamamoto1, Daisuke Hotta1, Shinya Tanaka2.
Abstract
BACKGROUND: A high coronary artery calcium score (CACS) predicts a poor prognosis in patients with coronary artery disease. We examined the relationship between the bifurcation angle and the CACS of the left main (LM) and left anterior descending (LAD) arteries in patients suffering from chronic kidney disease (CKD).Entities:
Mesh:
Substances:
Year: 2018 PMID: 29894482 PMCID: PMC5997324 DOI: 10.1371/journal.pone.0198566
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1A. Schematic representation of the LM-LAD arteries angle measurements. We identified the lines that delimited the LM-LAD angle, using the centre lines of the LM and LAD arteries on the volume rendering image. B, C. Representative example of mild coronary calcifications in a 69-year-old man. The LM–LAD arteries angle measured 23.9° and the CACS in the LM-LAD arteries was 14.7. D, E. Representative example of severe coronary calcifications in a 63-year-old man. The LM–LAD arteries angle measured 37.1° and the CACS in the LM-LAD arteries was 783. LM = left main artery; LAD = left anterior descending artery; LCX = left circumflex artery.
Baseline characteristics of 82 patients with <200 versus 39 patients with ≥200 coronary artery calcium score (CACS) of the left main (LM)-left anterior descending (LAD) arteries.
| CACS of LM-LAD arteries | |||
|---|---|---|---|
| <200 (n = 82) | ≥200 (n = 39) | ||
| Age (years) | 74.8±7.9 | 71.5±8.9 | 0.053 |
| Men | 49 (60) | 29 (74) | 0.117 |
| Body mass index | 24.0±4.0 | 23.8±3.6 | 0.797 |
| History of: | |||
| Diabetes mellitus | 17 (21) | 14 (36) | 0.074 |
| Hypertension | 64 (78) | 30 (77) | 0.889 |
| Dyslipidemia | 55 (67) | 34 (87) | 0.019 |
| Hemodialysis | 4 (5) | 8 (21) | 0.018 |
| Current smoking | 17 (21) | 10 (26) | 0.544 |
| Sleep apnea syndrome | 8 (10) | 4 (10) | 0.811 |
| Transient ischemic attack or stroke | 12 (15) | 6 (15) | 0.914 |
| Peripheral artery disease | 7 (9) | 9 (23) | 0.055 |
| Family history of coronary artery disease | 7 (9) | 1 (3) | 0.399 |
| History of drug therapy | |||
| Statin | 30 (37) | 17 (44) | 0.460 |
| Aspirin | 16 (20) | 11 (28) | 0.283 |
| Clopidogrel | 5 (6) | 5 (13) | 0.367 |
| Cilostazol | 2 (2) | 3 (8) | 0.175 |
| Ticlopidine | 2 (2) | 1 (3) | 0.967 |
| Angiotensin converting enzyme inhibitor or receptor blocker | 38 (46) | 17 (44) | 0.776 |
| Calcium channel blocker | 39 (48) | 19 (49) | 0.905 |
| Beta-adrenergic blocker | 23 (28) | 11 (28) | 0.986 |
| Vitamin D | 4 (5) | 4 (10) | 0.266 |
| Calcium carbonate | 3 (4) | 6 (15) | 0.054 |
| Warfarin | 11 (13) | 7 (18) | 0.512 |
| Blood pressure, mmHg | |||
| Systolic | 135±18 | 135±20 | 0.899 |
| Diastolic | 77±14 | 77±11 | 0.981 |
| Hemoglobin, g/dl | 13.3±1.7 | 13.1±2.0 | 0.575 |
| Hemoglobin A1c, % | 5.8±0.5 | 6.1±0.8 | 0.025 |
| Glucose, mg/dl | 113±37 | 122±42 | 0.214 |
| Cholesterol, mg/dl | |||
| Low-density lipoprotein | 106±30 | 109±41 | 0.715 |
| High-density lipoprotein | 56±16 | 49±15 | 0.026 |
| Low-density/high-density lipoprotein cholesterol ratio | 2.1±0.9 | 2.4±1.1 | 0.150 |
| Triglyceride, mg/dl | 143±88 | 161±92 | 0.324 |
| Estimated glomerular filtration rate, ml/min/1.73m2 | 48.9±12.2 | 41.6±19.6 | 0.036 |
| Corrected serum calcium, mg/dl | 9.2±0.4 | 9.1±0.5 | 0.436 |
| Degree of left main-left anterior descending coronary arteries angle | 33.8±11.6 | 40.3±10.0 | 0.003 |
Values are means ± standard deviations or numbers (%) of observations
Fig 2A weak positive correlation between the LM-LAD arteries angle and the CACS of the LM-LAD arteries (r = 0.269; p = 0.003).
Outcomes of single and multiple variable logistic regression analyses of correlates of CACS of the LM-LAD arteries <200 versus ≥200.
| ANALYSIS | ||||
|---|---|---|---|---|
| Single variable | Multiple variable | |||
| Odd ratio(95% CI) | Odd ratio(95% CI) | |||
| Age (years) | 0.25 (0.10–0.63) | 0.005 | 0.44 (0.14–1.37) | 0.153 |
| Men | 1.95 (0.84–4.54) | 0.172 | ||
| Body mass index | 0.43 (0.15–1.24) | 0.173 | ||
| History of: | ||||
| Diabetes mellitus | 2.14 (0.92–4.98) | 0.118 | ||
| Hypertension | 0.94 (0.38–2.33) | 0.925 | ||
| Dyslipidemia | 3.34 (1.17–9.50) | 0.033 | ||
| Hemodialysis | 5.03 (1.41–17.9) | 0.018 | ||
| Current smoking | 1.32 (0.54–3.23) | 0.709 | ||
| Sleep apnea syndrome | 1.06 (0.30–3.75) | 0.811 | ||
| Transient ischemic attack or stroke | 1.06 (0.37–3.07) | 0.869 | ||
| Peripheral artery disease | 3.21 (1.10–9.41) | 0.055 | ||
| Family history of coronary artery disease | 0.28 (0.03–2.38) | 0.399 | ||
| History of drug therapy | ||||
| Statin | 1.34 (0.62–2.91) | 0.590 | ||
| Aspirin | 1.62 (0.67–3.93) | 0.401 | ||
| Clopidogrel | 2.26 (0.61–8.34) | 0.367 | ||
| Cilostazol | 3.33 (0.53–20.8) | 0.385 | ||
| Ticlopidine | 1.05 (0.09–12.0) | 0.559 | ||
| Angiotensin converting enzyme inhibitor or receptor blocker | 0.89 (0.42–1.93) | 0.929 | ||
| Calcium channel blocker | 1.05 (0.49–2.25) | 0.940 | ||
| Beta-adrenergic blocker | 1.01 (0.43–2.35) | 0.843 | ||
| Vitamin D | 2.23 (0.53–9.43) | 0.471 | ||
| Calcium carbonate | 4.79 (1.13–20.3) | 0.054 | ||
| Warfarin | 1.41 (0.50–3.98) | 0.703 | ||
| Blood pressure, mmHg | ||||
| Systolic | 1.59 (0.61–4.13) | 0.477 | ||
| Diastolic | 0.32 (0.07–1.48) | 0.221 | ||
| Hemoglobin, g/dl | 0.42 (0.17–1.04) | 0.098 | ||
| Hemoglobin A1c, % | 3.63 (1.59–8.28) | 0.003 | 3.21 (1.25–8.46) | 0.015 |
| Glucose, mg/dl | 2.30 (1.04–5.05) | 0.059 | ||
| Cholesterol, mg/dl | ||||
| Low-density lipoprotein | 1.92 (0.89–4.16) | 0.141 | ||
| High-density lipoprotein | 0.30 (0.12–0.73) | 0.011 | 0.61 (0.21–1.69) | 0.344 |
| Low-density/high-density lipoprotein cholesterol ratio | 2.50 (1.14–5.45) | 0.033 | ||
| Triglyceride, mg/dl | 2.63 (1.14–6.09) | 0.036 | 2.78 (1.06–7.86) | 0.038 |
| Estimated glomerular filtration rate, ml/min/1.73m2 | 0.31 (0.12–0.75) | 0.015 | 0.29 (0.09–0.88) | 0.029 |
| Corrected serum calcium, mg/dl | 0.45 (0.20–1.00) | 0.075 | ||
| Degree of left main-left anterior descending coronary arteries angle | 5.87 (2.09–16.5) | <0.001 | 4.82 (1.68–16.1) | 0.030 |
Fig 3Comparison of diagnostic characteristics in model 1 (hemoglobin A1c, triglyceride, eGFR, LM-LAD arteries angle) versus model 2 (hemoglobin A1c, triglyceride, eGFR) to predict severe calcifications of the LM-LAD arteries.
The accuracy of the C statistics in the prediction of a high CACS in the LM-LAD arteries was increased by adding the measurement of the LM-LAD arteries angle (area under the curve = 0.816 in model 1 versus 0.769 in model 2).